Exelixis Overview
Latest P/E ratio for Exelixis: 16.44 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow16.44
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, EXEL shows a P/E ratio of 16.44. That is below the Healthcare sector average of 26.85. Scroll down for historical charts and peer comparison views.
The Healthcare sector average P/E ratio is about 26.85. Exelixis is at 16.44, which is lower that average. That is roughly 38.8% below the sector mean. Use the comparison chart on this page to see how EXEL stacks up against individual peers as well.
Investors watch EXEL's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Exelixis's latest reading is 16.44. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Exelixis's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 16.44) with ownership activity and broader fundamentals.
The Healthcare average P/E ratio is about 26.85, while EXEL is at 16.44. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
